SNMMI calls on CMS to cover PET agent Amyvid

02/3/2013 | DOTMed.com

SNMMI and other supporters of the PET imaging agent Amyvid are calling on CMS to provide coverage of the agent for diagnosis of Alzheimer's disease. The move follows a Medicare Evidence Development and Coverage Advisory Committee hearing where the panel questioned the utility of Amyvid in improving health outcomes. SNMMI said clinical evidence and FDA approval of the agent back "the ability of beta-amyloid imaging to change patient management, leading to better outcomes for patients."

View Full Article in:

DOTMed.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA